Betty J. Harris is Associate Professor of Pharmacy Practice and APPE Coordinator at Husson University's School of Pharmacy in Bangor, Maine. Prior to joining the faculty at Husson, Dr. Harris was Assistant Dean of Experiential Education and Student Services at NSU College of Pharmacy from 2006 to 2011. She joined academia after an extensive career in long-term care and specialty pharmacy care with Colonial Drugs and Pharmerica.
Prior to joining PharMerica, Dr. Harris practiced in community chain pharmacy and worked part-time in hospital settings. She is a graduate of the University of the Sciences in Philadelphia (formerly Philadelphia College of Pharmacy and Science) and received her Pharm.D. degree from Nova Southeastern University.
Dr. Harris is currently serving as the Treasurer of the Florida Pharmacy Association and Chair of the Policy Affairs Committee for AACP. Dr. Harris was appointed to the ACPE Board of Directors by APhA and served as a member from 2002 to 2008. She served as the 1998-99 Speaker of the APhA House of Delegates and as APhA Trustee from 1997 to 2002, Dr. Harris has served on APhA policy and reference committees. She is a past president and past speaker of the Florida Pharmacy Association (FPA), past Speaker of the FPA House of Delegates, and past president of the Florida Pharmacy Foundation, and has served as a trustee of the Foundation.
Hoelz, Derek, Ph.D.
Assistant Professor of Pharmacology, School of Pharmacy
Dr. Derek Hoelz joined Husson University School of Pharmacy as an Assistant Professor of Pharmacology in August, 2012. He earned a B.A. in Biology from Kent State University and a Ph.D. in Pharmacology and Experimental Therapeutics from the University of Maryland School of Medicine. Dr. Hoelz completed postdoctoral training in the Division of Hematology and Oncology at Indiana University School of Medicine.
After his postdoctoral training Dr. Hoelz transitioned into his first faculty position at Indiana University School of Medicine, during which time he co-founded a biotechnology company (CS-Keys, Inc.), which sought to develop more effective cancer diagnostics. In 2009, Dr. Hoelz joined the Maine Institute for Human Genetics and Health as a staff Scientist where he led a successful research laboratory investigating novel anticancer drug targets. Dr. Hoelz has been awarded numerous patents for his research, has authored several research articles, and has been awarded multiple research grants.